Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs.

Corrao G, Zambon A, Faini S, Bagnardi V, Leoni O, Suissa S.

J Clin Epidemiol. 2005 Jan;58(1):92-7.

PMID:
15649676
2.

Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.

Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB.

Ann Intern Med. 2008 Sep 16;149(6):380-90.

PMID:
18794557
3.

Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.

Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.

Ann Pharmacother. 2010 Apr;44(4):613-22. doi: 10.1345/aph.1M243.

PMID:
20233915
4.

Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.

Baker WL, Baker EL, Coleman CI.

Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.

PMID:
19637942
5.

Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.

Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.

Arch Intern Med. 2009 Aug 10;169(15):1403-10. doi: 10.1001/archinternmed.2009.233. Erratum in: Arch Intern Med. 2009 Sep 28;169(17):1568.

PMID:
19667304
6.

Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.

Gershon AS, Wang L, To T, Luo J, Upshur RE.

COPD. 2008 Aug;5(4):229-34. doi: 10.1080/15412550802237507.

PMID:
18671148
7.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium..

Ann Intern Med. 2007 Apr 17;146(8):545-55.

PMID:
17310045
8.

Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.

Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.

COPD. 2007 Jun;4(2):127-34.

PMID:
17530506
9.

Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest.

Lemaitre RN, Siscovick DS, Psaty BM, Pearce RM, Raghunathan TE, Whitsel EA, Weinmann SA, Anderson GD, Lin D.

Am J Med. 2002 Dec 15;113(9):711-6.

PMID:
12517359
10.

Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.

Kiri VA, Fabbri LM, Davis KJ, Soriano JB.

Respir Med. 2009 Jan;103(1):85-90. doi: 10.1016/j.rmed.2008.07.024.

11.
12.
13.

Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.

Lee TA, Schumock GT, Bartle B, Pickard AS.

Pharmacotherapy. 2009 Sep;29(9):1039-53. doi: 10.1592/phco.29.9.1039.

PMID:
19698009
14.

Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.

Puhan MA, Bachmann LM, Kleijnen J, Ter Riet G, Kessels AG.

BMC Med. 2009 Jan 14;7:2. doi: 10.1186/1741-7015-7-2.

15.
16.

Trends in pharmacotherapy for chronic airflow limitation in Argentina: 1992-2002.

Molfino NA.

Medicina (B Aires). 2004;64(5):407-12.

PMID:
15560541
18.

Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

Sobieraj DM, White CM, Coleman CI.

Clin Ther. 2008 Aug;30(8):1416-25. doi: 10.1016/j.clinthera.2008.08.004.

PMID:
18803985
19.

Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.

Chen AM, Bollmeier SG, Finnegan PM.

Ann Pharmacother. 2008 Dec;42(12):1832-42. doi: 10.1345/aph.1L250. Review.

PMID:
18957624
20.

The risk/benefit of inhaled corticosteroids in chronic obstructive pulmonary disease.

Bonay M, Bancal C, Crestani B.

Expert Opin Drug Saf. 2005 Mar;4(2):251-71. Review.

PMID:
15794718

Supplemental Content

Support Center